Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development

被引:220
作者
Pierson, Theodore C. [1 ]
Fremont, Daved H. [2 ,3 ]
Kuhn, Richard J. [6 ]
Diamond, Michael S. [2 ,3 ,4 ,5 ]
机构
[1] NIH, Viral Pathogenesis Sect, Viral Dis Lab, Bethesda, MD 20892 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[6] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/j.chom.2008.08.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Flaviviruses are a group of small RNA viruses that cause severe disease in humans worldwide and are the target of several vaccine development programs. A primary goal of these efforts is to elicit a protective humoral response directed against the envelope proteins arrayed on the surface of the flavivirus virion. Advances in the structural biology of these viruses has catalyzed rapid progress toward understanding the complexity of the flavivirus immunogen and the molecular basis of antibody-mediated neutralization. These insights have identified factors that govern the potency of neutralizing antibodies and will inform the design and evaluation of novel vaccines.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 79 条
  • [31] ANTIBODY-ENHANCED DENGUE VIRUS-INFECTION IN PRIMATE LEUKOCYTES
    HALSTEAD, SB
    OROURKE, EJ
    [J]. NATURE, 1977, 265 (5596) : 739 - 741
  • [32] ANTIBODIES THAT BLOCK VIRUS ATTACHMENT TO VERO CELLS ARE A MAJOR COMPONENT OF THE HUMAN NEUTRALIZING ANTIBODY-RESPONSE AGAINST DENGUE VIRUS TYPE-2
    HE, RT
    INNIS, BL
    NISALAK, A
    USAWATTANAKUL, W
    WANG, SL
    KALAYANAROOJ, S
    ANDERSON, R
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (04) : 451 - 461
  • [33] Heinz FX, 2004, ARCH VIROL, P201
  • [34] STRUCTURAL-CHANGES AND FUNCTIONAL CONTROL OF THE TICK-BORNE ENCEPHALITIS-VIRUS GLYCOPROTEIN-E BY THE HETERODIMERIC ASSOCIATION WITH PROTEIN PRM
    HEINZ, FX
    STIASNY, K
    PUSCHNERAUER, G
    HOLZMANN, H
    ALLISON, SL
    MANDL, CW
    KUNZ, C
    [J]. VIROLOGY, 1994, 198 (01) : 109 - 117
  • [35] Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): A case-control study
    Hennessy, S
    Liu, ZL
    Tsai, TF
    Strom, BL
    Wan, CM
    Liu, HL
    Wu, TX
    Yu, HJ
    Liu, QM
    Karabatsos, N
    Bilker, WB
    Halstead, SB
    [J]. LANCET, 1996, 347 (9015) : 1583 - 1586
  • [36] The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection
    Huang, Kao-Jean
    Yang, Yu-Ching
    Lin, Yee-Shin
    Huang, Jyh-Hsiung
    Liu, Hsiao-Sheng
    Yeh, Trai-Ming
    Chen, Shun-Hua
    Liu, Ching-Chuan
    Lei, Huan-Yao
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (05) : 2825 - 2832
  • [37] West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody
    Kaufmann, Barbel
    Nybakken, Grant E.
    Chipman, Paul R.
    Zhang, Wei
    Diamond, Michael S.
    Fremont, Daved H.
    Kuhn, Richard J.
    Rossmann, Michael G.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (33) : 12400 - 12404
  • [38] EVIDENCE THAT MATERNAL DENGUE ANTIBODIES ARE IMPORTANT IN THE DEVELOPMENT OF DENGUE HEMORRHAGIC-FEVER IN INFANTS
    KLIKS, SC
    NIMMANITYA, S
    NISALAK, A
    BURKE, DS
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 38 (02) : 411 - 419
  • [39] Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
    Kuhn, RJ
    Zhang, W
    Rossmann, MG
    Pletnev, SV
    Corver, J
    Lenches, E
    Jones, CT
    Mukhopadhyay, S
    Chipman, PR
    Strauss, EG
    Baker, TS
    Strauss, JH
    [J]. CELL, 2002, 108 (05) : 717 - 725
  • [40] Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains
    Kurane, I
    Takasaki, T
    [J]. VACCINE, 2000, 18 : 33 - 35